Mphasis Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MPHASIS, BSE:526299 Mphasis Ltd.

Mphasis Ltd.

14 May 2020

2315.90

1.20%

Mphasis (SELL): HP-DXC business losing steam; downgrade to SELL

Sell: Mphasis Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Mphasis (MPHL) reported a satisfactory Q4 on the back of (1) 1.5% QoQ/11.1% YoY CC revenue growth, (2) stable 16.3% EBIT margins, and (3) healthy deal wins.

Mphasis Ltd. is trading below its 100 day SMA of 2386.6

Mphasis Ltd.

14 May 2020

2315.90

1.20%

Decent performance; Soft outlook!

Neutral: Mphasis Ltd.

Target

Motilal Oswal

4QFY20 revenue growth at 1.5% (QoQ, CC) was marginally behind our estimates, as weakness in DXC channel overshadowed the healthy performance in Direct. Direct Core segment has been the growth driver and has seen strong deal In terms of capital allocation, MPHL will maintain its 55-57% payout policy. Maintain Given the uncertainty in the environment, management hinted at a soft outlook on revenue growth. However, the company is confident of maintaining its margins by using levers such as increase in share of Fixed Price Projects, fresher hiring, pyramid rationalization, automation and reduced travel costs etc. Direct Core segment has been the growth driver and has seen strong deal wins, Geography wise, Americas declined 1% QoQ while growth in Europe / RoW grew strong at 8%/9%.

Motilal Oswal released a Buy report for Mphasis Ltd. with a price target of 3100.0 on 31 May, 2026.

Mphasis Ltd.

14 May 2020

2315.90

1.20%

Mphasis Ltd.

Buy: Mphasis Ltd.

Recommendation Target

ICICI Securities Limited

The company is undertaking various measures for cost rationalisation like lower travel cost and lower discretionary spend. However, subdued revenues in DXC channel and anticipated utilisation pressure in the near term will impact FY21E margins. Hence, we expect FY21E EBIT margins to decline 90 bps YoY to 15.1% and see a recovery in FY22E leading to an...

Motilal Oswal released a Buy report for Mphasis Ltd. with a price target of 3100.0 on 31 May, 2026.

Mphasis Ltd.

14 May 2020

2315.90

1.20%

MphasiS

Buy: Mphasis Ltd.

Target

Dolat Capital

Strong Results; TCV and Commentary reassures growth Mphasis reported INR Revenue growth of 3.1% QoQ (1.5% QoQ in CC terms) ahead of estimates (1.4%) led by sustained traction in Direct International business (70% of revenue) that grew 2.6% QoQ in CC terms while DXC (26% of revenue) declined by 1% QoQ. OPM margin improved 10bps sequentially to 16.3% (our estm: 16.1%). PAT stood at Rs. 3.5Bn (our estm: 2.9Bn) due to lower tax out go at ~15%. MPHL added strong TCV wins at $201mn (TTM basis: $715mn, up 13%...

Mphasis Ltd. has an average target of 2718.50 from 6 brokers.

Mphasis Ltd.

18 Mar 2020

2315.90

1.20%

Mphasis Ltd.

Hold: Mphasis Ltd.

Target

ICICI Securities Limited

The spread of Covid-19 has led to lockdowns in many countries globally and could have adverse economic implications. In addition, the recent fall in crude prices could also have an adverse impact of fiscal health of oil producing countries. As a result, IT companies, which have considerable exposure to verticals such as oil, energy & utilities; banking & capital markets; manufacturing and travel & transport could see an adverse impact from the ongoing crisis. Companies like Wipro, Infosys in large cap and MindTree, NIIT Tech, Sonata software, Cyient, Accelya Solutions among...

Mphasis Ltd. has an average target of 2718.50 from 6 brokers.

Mphasis Ltd.

08 Feb 2020

2315.90

1.20%

DXC overhang remains, to weigh on multiples

Neutral: Mphasis Ltd.

Recommendation Target

Motilal Oswal

3QFY20 revenue growth of Mphasis (MPHL) (4% QoQ, CC) was largely in line with estimates; however, growth within key offerings like Application Development and Maintenance (~61% of revenue) remained tepid. We downgrade our FY20-22E EPS by 5-12%, driven by (a) continued uncertainty in growth trajectory of DXC channel, and (b) adjustments to our Revenue in CC terms grew 4.0% QoQ (v/s est. Growth was driven by Direct International (5% QoQ, CC) while DXC revenues remained largely Mphasis largest vertical, BFS, grew 5% QoQ, while Insurance was up ~6% QoQ. The restructuring that is underway at DXC seems to be impacting revenue growth in the channel. Growth was driven by Direct International (5% QoQ, CC) while DXC revenues remained largely BFS, Mphasis largest vertical grew 5% QoQ, while Insurance grew ~6% QoQ. Even non-core geographies like ROW made healthy contribution to segments reported strong growth (~6% / 15%, QoQ).

Mphasis Ltd. has an average target of 2718.50 from 6 brokers.

Mphasis Ltd.

07 Feb 2020

2315.90

1.20%

Mphasis (3QFY20): Direct Core-Digital Risk offsets DXC softness. Maintain BUY

Buy: Mphasis Ltd.

Target

HDFC Securities

Mphasis' growth profile is supported by traction in Direct Core, sustainable recovery in Digital Risk (cross-sell) even as the FY17-19 DXC-HP growth delta fades. Strong deal trajectory (USD 189mn TCV NN in 3Q) largely in new-gen services, strong traction in T2-10 accounts and new logo/Blackstone portfolio (2 logos in T20) are expected to drive growth. Expect 10.3/12.1% USD rev/EPS CAGR over FY20-22E. We maintain BUY on Mphasis following a strong Direct Core-Digital Risk performance. Growth drivers in Direct Core are intact, but DXC-HP risks persist. Our TP of Rs 1,010 values Mphasis at 14x Dec-21E EPS (at 5-yr avg vs. 16x earlier) resetting target valuations to adequately reflect risk-reward.

Mphasis Ltd. has an average target of 2718.50 from 6 brokers.

Mphasis Ltd.

07 Feb 2020

2315.90

1.20%

Mphasis (ADD): Cloudy DXC/HP visibility overshadows strong operating beat

Mphasis Ltd.

BOB Capital Markets Ltd.

Mphasis (MPHL) reported a beat on both revenue and margins in Q3FY20.

Mphasis Ltd. is trading below its 100 day SMA of 2386.6

Mphasis Ltd.

07 Feb 2020

2315.90

1.20%

Mphasis Ltd.

Hold: Mphasis Ltd.

Target

ICICI Securities Limited

Mphasis has reported healthy growth in Direct international channel. Growth in this segment is expected to be healthy led by higher deal wins, higher focus on new gen technologies and focus on wining deals upstream. To this end, the company has won a TCV of US$189 million (up 8.6% QoQ) of which US$164 million (or 87%) is in new generation services, which is positive for long term revenue and margin perspective. Considering robust deal wins coupled with improvement in Blackstone portfolio companies (which now contribute 7% will be in double digit in coming years) we expect Direct...

Motilal Oswal released a Buy report for Mphasis Ltd. with a price target of 3100.0 on 31 May, 2026.

Mphasis Ltd.

18 Nov 2019

2315.90

1.20%

First Light | Mphasis, Trade, KNR Constructions, Ashoka Buildcon, PNC Infratech

Buy: Mphasis Ltd.

BOB Capital Markets Ltd.

MPHL: Cut to ADD on HP/DXC channel uncertainty. Trade: Imports see a sharp dip, exports steady. KNRC: Strong quarter; revenue guidance cut on project delays. ASBL: Subdued execution, growth to pick up in H2. PNCL: Strong quarter, momentum to continue

Mphasis Ltd. is trading below its 100 day SMA of 2386.6

Is MphasiS Ltd. worth buying?

256 Votes:

Buy 78.91%

Sell 11.72%

Hold 9.38%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf